OLIVIA SAAVEDRA: Open Payments
NPI 1497328124 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 9 payments from 6 companies in 2025. Trend: 2023 $87 · 2024 $109 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| GE HEALTHCARE | 3 | $50 |
| ACADIA Pharmaceuticals Inc | 2 | $45 |
| UCB, Inc. | 1 | $44 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
Products named: NUPLAZID, Fintepla, CREXONT, Symbravo, QULIPTA.
Industry payments across TX — which companies pay providers there.
